- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Major Tool for Gene Hunting Unveiled
26 October 2005 (All day)
Three years after it was launched with high hopes, the first, massive phase of the International HapMap Project is complete. The goal is to help locate genes behind complex diseases such as diabetes. Francis Collins, director of the National Human Genome Research Institute in Bethesda, Maryland, and a key participant, calls the map "a dream come true." He and others are concerned, however, that, as with any novel tool, researchers may be reluctant to apply it. One reason is that some questions remain about the map's usefulness.
The $138 million HapMap denotes haplotypes, stretches of DNA that are inherited together as unbroken blocks and can be identified by just a handful of DNA markers known as SNPS (single nucleotide polymorphisms). The map allows gene hunters to get away with less (and thus cheaper) DNA sequencing while still, it's hoped, homing in on disease genes. Data from the map, which are freely available online, are already helping narrow the search for genes involved in macular degeneration, dyslexia, and hypertension.
An international consortium led by David Altshuler of the Broad Institute in Cambridge, Massachusetts, and Peter Donnelly of Oxford University in the U.K., announced the draft's completion today at the annual meeting of the American Society of Human Genetics in Salt Lake City, Utah; the map was also published in the 27 October Nature. In a sign of both a desire to exploit the HapMap and confusion about how to do so, more than 500 scientists have signed up for a session at the meeting on how to glean the most from the map.
"The world will be able to use this forever," says David Cox, chief scientific officer of Perlegen Sciences in Mountainview, California, whose company made available in February a HapMap it created. But concern lingers about how the HapMap will perform in the hunt for disease genes. While the Perlegen HapMap differs somewhat from the HapMap created by the international consortium map, says Cox, both should point gene hunters to similar DNA regions--though that hasn't been put to a rigorous test.
International HapMap Project